We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.65B
1-Year Est. Return 18.1%
This Fund
S&P 500
This Quarter Est. Return
+8.66%
1 Year Est. Return
+18.1%
3 Year Est. Return
+53.4%
5 Year Est. Return
+63.18%
10 Year Est. Return
+288.04%
AUM
$1.05B
AUM Growth
+$87.6M
Cap. Flow
+$11M
Cap. Flow %
1.05%
Top 10 Hldgs %
25.51%
Holding
257
New
6
Increased
69
Reduced
106
Closed
4

Top Buys

Rank Stock Value
1
MRSH
Marsh
MRSH
+$16.4M
2
ATR icon
AptarGroup
ATR
+$2.92M
3
CVX icon
Chevron
CVX
+$970K
4
WM icon
Waste Management
WM
+$911K
5
MSFT icon
Microsoft
MSFT
+$677K

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$1.49M
2
AAPL icon
Apple
AAPL
+$1.01M
3
PM icon
Philip Morris
PM
+$958K
4
CELG
Celgene Corp
CELG
+$924K
5
XOM icon
ExxonMobil
XOM
+$883K

Sector Composition

Rank Sector Weight
1 Technology 18.67%
2 Healthcare 16.26%
3 Miscellaneous 13.33%
4 Financials 11.97%
5 Industrials 9.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXP icon
101
American Express
AXP
$219B
$2.28M 0.22%
18,318
– –
WELL icon
102
Welltower
WELL
$168B
$2.23M 0.21%
27,316
+76
+0.3% +$6.51K
VXF icon
103
Vanguard Extended Market ETF
VXF
$30.6B
$2.14M 0.2%
16,996
+44
+0.3% +$5.31K
TGT icon
104
Target
TGT
$70.1B
$2.08M 0.2%
16,195
– –
ADI icon
105
Analog Devices
ADI
$175B
$2.07M 0.2%
17,398
-355
-2% -$40K
XRAY icon
106
Dentsply Sirona
XRAY
$1.98B
$2.02M 0.19%
35,791
– –
DEO icon
107
Diageo
DEO
$48.3B
$2.02M 0.19%
11,999
+226
+2% +$36.7K
NOW icon
108
ServiceNow
NOW
$147B
$1.97M 0.19%
34,805
+2,075
+6% +$109K
IBM icon
109
IBM
IBM
$233B
$1.95M 0.19%
15,240
-3,975
-21% -$517K
HUBB icon
110
Hubbell
HUBB
$23.1B
$1.94M 0.18%
13,110
-140
-1% -$19.9K
QCOM icon
111
Qualcomm
QCOM
$200B
$1.9M 0.18%
21,490
– –
BSX icon
112
Boston Scientific
BSX
$63.7B
$1.87M 0.18%
41,280
-1,200
-3% -$50.2K
WAB icon
113
Wabtec
WAB
$47B
$1.84M 0.18%
23,678
-7,110
-23% -$526K
VEA icon
114
Vanguard FTSE Developed Markets ETF
VEA
$234B
$1.84M 0.18%
41,751
+125
+0.3% +$5.33K
TT icon
115
Trane Technologies
TT
$93.1B
$1.8M 0.17%
13,580
– –
NVS icon
116
Novartis
NVS
$264B
$1.75M 0.17%
18,518
-5,589
-23% -$501K
ALC icon
117
Alcon
ALC
$32.8B
$1.73M 0.16%
30,575
+705
+2% +$40.4K
IVV icon
118
iShares Core S&P 500 ETF
IVV
$836B
$1.72M 0.16%
5,326
+804
+18% +$249K
FDX icon
119
FedEx
FDX
$73.1B
$1.66M 0.16%
10,988
-702
-6% -$108K
NTRS icon
120
Northern Trust
NTRS
$32.7B
$1.66M 0.16%
15,585
-1,791
-10% -$183K
ILMN icon
121
Illumina
ILMN
$33.9B
$1.6M 0.15%
4,965
-26
-0.5% -$7.88K
COST icon
122
Costco
COST
$399B
$1.59M 0.15%
5,410
+1,395
+35% +$415K
K
123
DELISTED
Kellanova
K
$1.56M 0.15%
24,060
-895
-4% -$54.2K
STX icon
124
Seagate
STX
$175B
$1.55M 0.15%
26,000
– –
GLW icon
125
Corning
GLW
$124B
$1.54M 0.15%
52,982
-900
-2% -$26.1K
3 4
5
6 7

Similar funds

MCIL
MFF Capital Investments Ltd Sydney $1.65B AUM
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return
SOS
Silver Oak Securities Jackson, Tennessee $1.65B AUM 29.37% 1-Year Est. Return
GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
NPA
Nichols & Pratt Advisers Boston, Massachusetts $1.65B AUM 22.9% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.65B AUM 26.32% 1-Year Est. Return
OHIF
Oriental Harbor Investment Fund Hong Kong $1.65B AUM 184.75% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return

Boston Family Office's Q4 2019 Portfolio in Review

As of Q4 2019, Boston Family Office held 257 positions worth $1.05B, up 9.1% from $964M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 3.9%. Boston Family Office opened 6 new positions and exited 4, leaving the 257-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Miscellaneous.

  • Boston Family Office's largest Q4 2019 buy was Constellation Brands: 1,475 shares worth $280K.
  • Boston Family Office added most to Marsh in Q4 2019, an estimated $16.4M increase.
  • Boston Family Office's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $1.49M.
  • Boston Family Office fully exited Celgene Corp in Q4 2019, selling an estimated $924K.
  • Boston Family Office's ten largest holdings make up 26% of its $1.05B portfolio in Q4 2019.
  • Boston Family Office opened 6 new positions and closed 4 in Q4 2019.
  • Boston Family Office's portfolio value rose 9.1% quarter-over-quarter to $1.05B.

Based on Boston Family Office's 13F filing for Q4 2019, filed 5 Feb 2020.